Cervicogenic Headache vs Migraine: Why Your KL Head Spa Treats Both

Two Headaches, One Anatomical Convergence

Clinicians distinguish between migraine (a neurovascular disorder of the trigeminal system) and cervicogenic headache (pain referred from the upper cervical spine and suboccipital musculature). In practice, the distinction is frequently blurred — and for good reason. Both headache types share a critical anatomical node: the trigeminocervical complex.

Understanding this convergence explains why a correctly targeted scalp and cervical therapy treats both conditions effectively, and why misidentifying one as the other leads to years of inadequate treatment.

What Is Cervicogenic Headache?

Cervicogenic headache (CGH) originates from structures in the upper cervical spine — predominantly the C1–C3 vertebral joints, the suboccipital muscles (rectus capitis posterior major and minor, obliquus capitis superior and inferior), and the greater and lesser occipital nerves that emerge from C2–C3.

Pain is referred upward and forward — typically presenting as a unilateral, non-pulsating ache that begins at the base of the skull and radiates to the forehead, temple, or eye. It is commonly accompanied by:

• Restricted cervical range of motion
• Tenderness at the suboccipital ridge on the ipsilateral side
• Worsening with sustained neck posture (reading, screen use, driving)
• No nausea, photophobia, or aura — features that distinguish it from migraine

The International Headache Society estimates CGH accounts for approximately 20% of chronic headache presentations — yet it is routinely misclassified as tension headache or migraine, and treated with analgesics rather than cervical mobilisation.

The Trigeminocervical Complex: Where the Two Headaches Meet

The trigeminocervical complex is a region of the upper cervical spinal cord where the trigeminal nucleus caudalis (the pain-processing centre for the face and head) receives convergent synaptic input from both:

• Trigeminal afferents (meningeal vessels, scalp, face)
• Cervical afferents from C1–C3 (suboccipital muscles, upper cervical joints, occipital nerve)

This anatomical convergence means that nociceptive signals from the upper cervical spine can sensitise the trigeminal nucleus and produce pain perceived in the head — even without any primary intracranial pathology. Conversely, migraine-driven central sensitisation in the trigeminal nucleus caudalis lowers the threshold for cervical input to produce pain — which is why many migraine patients also experience neck stiffness and occipital tenderness.

The practical implication: cervical dysfunction can trigger migrainous episodes, and migraine central sensitisation amplifies cervicogenic pain. They are not mutually exclusive, and treatment addressing only one axis will produce incomplete results.

Screen Culture, Forward Head Posture, and the 400% Load

KL's professional workforce is among the most screen-intensive in Southeast Asia — with average screen time exceeding 8 hours daily across work and leisure. The cervical consequence is significant.

Forward head posture (FHP) — the anterior translation of the skull relative to the shoulder girdle — increases the effective mechanical load on the suboccipital and upper cervical structures. Biomechanical modelling by Hansraj (2014) quantified this:

• Neutral posture (ears over shoulders): cervical load ~5 kg
• 15° forward tilt: ~12 kg
• 30° forward tilt: ~18 kg
• 45° forward tilt: ~22 kg
• 60° forward tilt (typical smartphone posture): ~27 kg — approximately 400% the neutral load

This sustained mechanical overload fatigues the suboccipital muscles, compresses the C1–C3 facet joints, and chronically loads the greater and lesser occipital nerves. The result is a continuous nociceptive input to the trigeminocervical complex that both generates cervicogenic headache and primes the trigeminal system for migraine.

Clinical Differentiation: CGH vs Migraine

| Feature | Cervicogenic Headache | Migraine | |---|---|---| | Pain quality | Non-pulsating, dull ache | Pulsating, throbbing | | Side | Consistently unilateral, same side | Can switch sides | | Nausea/vomiting | Absent | Present in moderate-severe | | Photophobia | Absent | Present | | Aura | Absent | Present in ~30% | | Neck movement | Worsens headache | No consistent relationship | | Occipital tenderness | Characteristic | During allodynia phase only | | Duration | Hours to days | 4–72 hours (untreated) |

Many patients present with mixed phenotype — cervicogenic triggers amplifying a migrainous substrate. These patients are the clearest candidates for a dual-protocol cervical and scalp intervention.

TTE's Suboccipital and Temporal Protocol

TTE Elephant's cervicogenic protocol targets the anatomical pain generators directly:

Suboccipital release — sustained manual compression at the suboccipital ridge deactivates myofascial trigger points in the rectus capitis posterior and obliquus capitis muscles. This reduces the continuous nociceptive afferent load reaching the trigeminocervical complex and provides decompression of the C2 nerve root (greater occipital nerve).

Greater occipital nerve mobilisation — the GON pierces the semispinalis capitis muscle and trapezius fascia before reaching the scalp. Fascial restriction at these points is a common and underrecognised compression site. Targeted fascial release along the GON pathway reduces the entrapment component of occipital neuralgia that frequently co-occurs with CGH.

Temporal fascia release — the temporalis muscle fascia is addressed for its contribution to the temporal and periorbital referral pattern common in both CGH and tension headache. This also reduces jaw and bite loading that contributes to temporomandibular-driven headache.

Vagal stimulation component — occipital ridge compression stimulates vagal afferents converging at C1–C3, activating parasympathetic dominance and suppressing sympathetic tone. This creates the neurological context for central sensitisation reversal.

FAQ

Q: How do I know if my headache is cervicogenic or migraine? A: The clearest distinguishing features are: (1) whether neck movement or sustained posture consistently triggers or worsens the headache (CGH); (2) whether you experience nausea, light sensitivity, or visual aura (migraine); and (3) whether suboccipital tenderness is present at rest versus only during headache (CGH vs migraine allodynia). A clinical assessment — including cervical range of motion testing and suboccipital palpation — is the most reliable differentiation tool.

Q: Can I have both cervicogenic headache and migraine? A: Yes. Mixed-phenotype headache — cervicogenic triggers amplifying a migrainous substrate — is common, particularly among screen-heavy professionals. In these patients, cervical dysfunction continuously lowers the migraine threshold, resulting in higher attack frequency than migraine alone would produce. Addressing the cervical component often reduces migraine frequency even without direct migraine-specific treatment.

Q: Does forward head posture from phone use really cause headaches? A: The biomechanical evidence is clear: 60° of forward head tilt increases cervical load to approximately 27 kg — 400% of the neutral 5 kg baseline. Sustained exposure fatigues the suboccipital muscles and loads the C1–C3 facet joints, creating the myofascial and articular nociception that drives cervicogenic headache. For most KL professionals, this is a daily, multi-hour exposure.

Q: Is cervicogenic headache treated differently from migraine? A: The primary treatment for cervicogenic headache is cervical mobilisation, suboccipital muscle release, and postural correction — not pharmacological management, which is the first line for migraine. Analgesics will temporarily reduce CGH pain but will not address the cervical dysfunction generating it. This is why many patients with unrecognised CGH experience inadequate response to migraine medications.

Q: How quickly does suboccipital release provide relief? A: For acute cervicogenic headache with clear suboccipital trigger points, myofascial release frequently produces within-session pain reduction. Long-term results — reduced attack frequency and severity — require consistent treatment over 4–6 sessions to address the accumulated muscular and fascial dysfunction, combined with postural modification to reduce the ongoing mechanical load.